Cargando…
Insights into the Molecular Mechanisms Behind Intralesional Immunotherapies for Advanced Melanoma
The incidence of cutaneous melanoma, a highly malignant skin cancer, is increasing yearly. While surgical removal of the tumor is the mainstay of treatment for patients with locally confined disease, those with metastases face uncertainty when it comes to their treatment. As melanoma is a relatively...
Autores principales: | Vidovic, Dejan, Giacomantonio, Carman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281646/ https://www.ncbi.nlm.nih.gov/pubmed/32455916 http://dx.doi.org/10.3390/cancers12051321 |
Ejemplares similares
-
Abscopal responses in patients with metastatic melanoma involving skin and subcutaneous tissues treated with intralesional IL2 plus BCG
por: Vidovic, Dejan, et al.
Publicado: (2023) -
Cutaneous Breast Cancer Metastasis Is Effectively Treated With Intralesional Interleukin-2 and Imiquimod: A Case Report and Brief Literature Review
por: Drohan, Ashley, et al.
Publicado: (2022) -
Talimogene Laherparepvec (T-VEC): An Intralesional Cancer Immunotherapy for Advanced Melanoma
por: Ferrucci, Pier Francesco, et al.
Publicado: (2021) -
Resolution of Metastatic Subungal Eccrine Porocarcinoma Treated with Intralesional Interleukin-2
por: Drohan, Ashley, et al.
Publicado: (2020) -
Topical and Intralesional Immunotherapy for Melanoma In Situ: A Review
por: Martínez-Fernández, Sandra, et al.
Publicado: (2023)